Adrian R. Krainer, Director at Stoke Therapeutics, Inc. (STOK), sold 66,486 shares at $39.74 ($2.6M) on 2026-03-10, disclosed to the SEC on 2026-03-12.
Open-market sale of $2.6M STOK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.74 | 33,243 | $1.3M | 50.0% |
| 2 | $39.74 | 33,243 | $1.3M | 50.0% |
| Total | $39.74 avg | 66,486 | $2.6M | 100% |
| Filing → |
| STOK | SELL | 2025-11-18 | $2.2M | — | Filing → |